TELA Bio Inc (TELA): Next-Year EPS Estimate 35.67%
As of 2026-10-23, TELA Bio Inc (TELA) has a next-year EPS growth estimate of 35.67%. Featured in 3 EPS revision reports, most recently on 2026-09-11.
On 2026-10-19, analyst consensus for TELA's next-year EPS growth shifted from 35.22% to 35.67% — a positive change of 0.45 percentage points. The revised estimate has been sustained across 5 subsequent trading sessions. Current-year growth is projected at 16.97%.
What's Driving This
TELA’s rise appears primarily driven by the September 3, 2026 upward EPS-growth estimate revision, from 25.80% to 34.22%. Recent Q2 2026 earnings-call and results headlines do not clearly identify a beat, guidance raise, contract win, or product launch directly tying to that upgrade. The estimate has since edged up another 0.45 pp
Generated 2026-10-19 from news as of 2026-10-19
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Devices
- EPS growth next year
- 35.67%
- EPS growth this year
- 16.97%
- EPS next quarter (est)
- -$0.16
- Last price
- $0.96
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-10-23 | 35.67% | 16.97% | -$0.16 | $0.96 |
| 2026-10-22 | 35.67% | 16.97% | -$0.16 | $1.01 |
| 2026-10-21 | 35.67% | 16.97% | -$0.16 | $1.08 |
| 2026-10-20 | 35.67% | 16.97% | -$0.16 | $1.09 |
| 2026-10-19 | 35.67% | 16.97% | -$0.16 | $0.97 |
| 2026-10-16 | 35.22% | 17.96% | -$0.16 | $0.98 |
| 2026-10-15 | 35.22% | 17.96% | -$0.16 | $1.01 |
| 2026-10-14 | 35.22% | 17.96% | -$0.16 | $1.10 |
| 2026-10-13 | 35.22% | 17.96% | -$0.16 | $1.07 |
| 2026-10-12 | 35.22% | 17.96% | -$0.16 | $1.08 |
| 2026-10-11 | 35.22% | 17.96% | -$0.16 | $1.11 |
| 2026-10-10 | 35.22% | 17.96% | -$0.16 | $1.11 |
| 2026-10-09 | 35.22% | 17.96% | -$0.16 | $1.11 |
| 2026-10-08 | 35.22% | 17.96% | -$0.16 | $1.05 |
| 2026-10-07 | 35.22% | 17.96% | -$0.16 | $1.07 |
| 2026-10-06 | 35.22% | 17.96% | -$0.16 | $1.09 |
| 2026-10-05 | 35.22% | 17.96% | -$0.16 | $1.14 |
| 2026-10-04 | 35.22% | 17.96% | -$0.16 | $1.14 |
| 2026-10-03 | 35.22% | 17.96% | -$0.16 | $1.14 |
| 2026-10-02 | 35.22% | 17.96% | -$0.16 | $1.14 |
| 2026-10-01 | 35.22% | 17.96% | -$0.16 | $1.25 |
| 2026-09-30 | 35.22% | 17.96% | -$0.16 | $1.15 |
| 2026-09-29 | 35.22% | 17.96% | -$0.16 | $1.24 |
| 2026-09-28 | 35.22% | 17.96% | -$0.16 | $1.23 |
| 2026-09-27 | 35.22% | 17.96% | -$0.16 | $1.26 |
| 2026-09-25 | 35.22% | 17.96% | -$0.16 | $1.26 |
| 2026-09-24 | 34.22% | 17.69% | -$0.16 | $1.27 |
| 2026-09-23 | 34.22% | 17.69% | -$0.16 | $1.30 |
| 2026-09-22 | 34.22% | 17.69% | -$0.16 | $1.41 |
| 2026-09-21 | 34.22% | 17.69% | -$0.16 | $1.30 |
Reports Featuring TELA
Recent News
- TELA Bio Inc (TELA) (Q2 2026) Earnings Call Highlights: Navigating PRS Headwinds and Strategic ...GuruFocus.com
- TELA Bio, Inc. Q2 2026 Earnings Call SummaryMoby
- TELA Bio Reports Second Quarter 2026 Financial ResultsGlobeNewswire
- Earnings To Watch: TELA Bio Inc (TELA) Q2 2026 -- GF Value Sees 97% UpsideGuruFocus.com
- TELA Bio Inc (TELA) Q4 2025 Earnings Call Highlights: Record Revenue Growth Amid Strategic ...GuruFocus.com
- TELA Bio Reports Fourth Quarter and Full Year 2025 Financial ResultsGlobeNewswire
- TELA Bio Inc (TELA) Q4 2025: Everything You Need To Know Ahead Of EarningsGuruFocus.com
Screen Performance
Aggregate stats across all 2095 tickers our top-EPS-revision screen has flagged over the past 205 days.
- Median return since detection
- -2.6%
- % of tickers in the green
- 44%
- Median return on winners
- +22.6%
- Large revisions captured
- 1936
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is TELA Bio Inc's next-year EPS growth estimate?▾
As of 2026-10-23, TELA Bio Inc (TELA) has a next-year EPS growth estimate of 35.67%, based on analyst consensus.
When was the latest EPS estimate revision for TELA?▾
The most recent revision occurred on 2026-10-19, when analysts adjusted the next-year EPS growth estimate from 35.22% to 35.67%.
What sector and industry does TELA Bio Inc belong to?▾
TELA Bio Inc operates in the Healthcare sector, specifically the Medical Devices industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. TELA appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. TELA Bio Inc (TELA) appears here because it was detected by our daily top-EPS-revision-performer screen.